Frame P S, Fryback D G, Patterson C
Tri-County Family Medicine Program, Dansville, NY.
Ann Intern Med. 1993 Sep 1;119(5):411-6. doi: 10.7326/0003-4819-119-5-199309010-00010.
To evaluate the cost-effectiveness of screening by physical examination or abdominal ultrasonography for abdominal aortic aneurysm (AAA) in men aged 60 to 80 years.
A systematic review of the pertinent literature by the Canadian Task Force on the Periodic Health Examination, augmented by an additional computerized search (MEDLINE) and references identified from bibliographies of pertinent articles. Several experts reviewed the data for completeness.
Published English-language studies that present data relevant to screening for abdominal aortic aneurysm.
Several reviewers determined a range of data and the most probable value for each parameter.
A computer spreadsheet model was constructed to simulate the costs and effectiveness of various screening protocols in a cohort of 10,000 men during a period of 20 years. The primary cost-effectiveness measure computed was incremental present-value dollar expenditures for screening and treatment per incremental present-value life-year saved by the screening program. Using the "most probable" values for the simulation parameters, a single screening procedure of abdominal palpation followed by abdominal ultrasound scan for patients with positive screening results is estimated to gain 20 life-years at a cost of $28,741 per life-year. A single ultrasound screen gains 57 life-years at a cost of $41,550 per life-year. A repeated ultrasound screen after 5 years gains 1 additional life-year at a cost of $906,769.
A single screen for AAA by abdominal palpation in men from age 60 to 80 years might be considered cost-effective but of small benefit. A single screen with ultrasonography is at the high end of the cost-per-life-year range that might be considered cost-effective and also is of modest benefit. Repeated screening is not cost-effective.
评估对60至80岁男性进行体格检查或腹部超声筛查腹主动脉瘤(AAA)的成本效益。
加拿大定期健康检查特别工作组对相关文献进行的系统综述,并通过额外的计算机检索(MEDLINE)以及从相关文章的参考文献中识别出的文献进行补充。多位专家对数据的完整性进行了审查。
发表的英文研究,其提供了与腹主动脉瘤筛查相关的数据。
多位评审员确定了一系列数据以及每个参数的最可能值。
构建了一个计算机电子表格模型,以模拟在20年期间对10,000名男性队列中各种筛查方案的成本和效果。计算的主要成本效益指标是筛查计划每挽救一个增量现值生命年,筛查和治疗的增量现值美元支出。使用模拟参数的“最可能”值,对于筛查结果呈阳性的患者,先进行腹部触诊,然后进行腹部超声扫描的单次筛查程序估计可挽救20个生命年,每个生命年的成本为28,741美元。单次超声筛查可挽救57个生命年,每个生命年的成本为41,550美元。5年后重复进行超声筛查可多挽救1个生命年,成本为906,769美元。
对60至80岁男性进行单次腹主动脉瘤腹部触诊筛查可能具有成本效益,但益处较小。单次超声筛查处于可能被认为具有成本效益的每生命年成本范围的高端,且益处也不大。重复筛查不具有成本效益。